MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617082501 A) filed by The University Of Liverpool on July 04, 2026, for Nucleic Acid Construct Comprising Nucleic Acid Sequences Encoding Immunogenic Peptides Derived From Zika Virus.
Inventors include French, Neil; Subramaniam, Krishanthi; Blanchard, Tom; Turtle, Lance; and Carroll, Miles.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: A nucleic acid construct comprising nucleic acid sequences encoding at least two of: a) An immunogenic peptide having at least 70% sequence homology to a portion of the pre-membrane (prM) structural protein of Zika virus; b) An immunogenic peptide having at least 70% sequence homology to a portion of the envelope (E or Env) structural protein of Zika virus; c) an immunogenic peptide having at least 70% sequence homology to a portion of the non-structural protein 5 (NS5) of Zika virus; and/or d) an immunogenic peptide having at least 70% sequence homology to a portion of the non-structural protein 3 (NS3) of Zika virus.
Disclaimer: Curated by HT Syndication.
